Cullinan Therapeutics, Inc. (CGEM)
21.85
+0.17
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
21.85
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Market Cap : 1.410B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.399B |
| August 20, 2026 | 1.380B |
| August 19, 2026 | 1.454B |
| August 18, 2026 | 1.345B |
| August 17, 2026 | 1.329B |
| August 14, 2026 | 1.313B |
| August 13, 2026 | 1.268B |
| August 12, 2026 | 1.265B |
| August 11, 2026 | 1.267B |
| August 10, 2026 | 1.180B |
| August 07, 2026 | 1.144B |
| August 06, 2026 | 1.159B |
| August 05, 2026 | 1.137B |
| August 04, 2026 | 1.133B |
| August 03, 2026 | 1.006B |
| July 31, 2026 | 1.022B |
| July 30, 2026 | 1.085B |
| July 29, 2026 | 1.066B |
| July 28, 2026 | 1.082B |
| July 27, 2026 | 1.079B |
| July 24, 2026 | 1.059B |
| July 23, 2026 | 1.070B |
| July 22, 2026 | 1.093B |
| July 21, 2026 | 1.119B |
| July 20, 2026 | 1.084B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.096B |
| July 16, 2026 | 1.016B |
| July 15, 2026 | 1.104B |
| July 14, 2026 | 1.101B |
| July 13, 2026 | 1.107B |
| July 10, 2026 | 1.123B |
| July 09, 2026 | 1.138B |
| July 08, 2026 | 1.141B |
| July 07, 2026 | 1.125B |
| July 06, 2026 | 1.103B |
| July 02, 2026 | 1.092B |
| July 01, 2026 | 1.070B |
| June 30, 2026 | 1.128B |
| June 29, 2026 | 1.141B |
| June 26, 2026 | 1.140B |
| June 25, 2026 | 1.145B |
| June 24, 2026 | 1.093B |
| June 23, 2026 | 1.099B |
| June 22, 2026 | 1.071B |
| June 18, 2026 | 930.86M |
| June 17, 2026 | 894.32M |
| June 16, 2026 | 839.20M |
| June 15, 2026 | 842.91M |
| June 12, 2026 | 848.49M |
| June 11, 2026 | 803.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rallybio Corp. | 89.16M |
| MapLight Therapeutics, Inc. | 515.71M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
Market Cap Related Metrics
| Price to Book Value | 4.384 |
| Price | 21.85 |
| Earnings Yield | -15.53% |